Y-mAbs Therapeutics, Inc. (YMAB) Social Stream



Y-mAbs Therapeutics, Inc. (YMAB): $12.40

0.45 (-3.50%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add YMAB to Watchlist
Sign Up

Y-MABS THERAPEUTICS INC (YMAB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering YMAB.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $68 $39 $54.4 $6.82 697.65%
2021-11-16 6 $68 $30 $49 $6.82 618.48%
2021-12-22 6 $68 $25 $46.2 $6.82 577.42%
2022-01-03 6 $68 $25 $45.6 $6.82 568.62%
2022-01-06 6 $68 $25 $43.4 $6.82 536.36%
2022-02-17 6 $68 $15 $41.4 $6.82 507.04%
2022-02-25 6 $68 $15 $40 $6.82 486.51%
2022-02-28 6 $63 $15 $35.8 $6.82 424.93%
2022-04-21 6 $63 $15 $33.8 $6.82 395.6%
2022-05-10 6 $63 $15 $30.8 $6.82 351.61%
2022-06-07 6 $63 $15 $29 $6.82 325.22%
2022-08-13 8 $63 $15 $29.571 $6.82 333.59%
2022-08-15 8 $63 $15 $29.285 $6.82 329.4%
2022-10-26 8 $63 $16 $29.571 $6.82 333.59%
2022-10-28 8 $63 $16 $28.857 $6.82 323.12%
2022-10-31 8 $27 $6 $16.875 $6.82 147.43%
2022-11-09 8 $27 $6 $15 $6.82 119.94%
2022-12-02 8 $27 $4 $13.285 $6.82 94.79%
2022-12-15 8 $27 $4 $13.142 $6.82 92.7%
2023-01-05 8 $20 $5 $12.285 $6.82 80.13%
2023-01-26 8 $20 $5 $12.285 $6.82 80.13%
2023-01-27 8 $20 $4 $12 $6.82 75.95%
2023-02-08 8 $20 $4 $12.142 $6.82 78.04%
2023-03-31 7 $20 $4 $12.142 $6.82 78.04%
2023-04-04 7 $18 $4 $10.714 $6.82 57.1%
2023-05-09 7 $21 $4 $11.142 $6.82 63.37%
2023-05-10 7 $21 $6 $12.714 $6.82 86.42%
2023-05-15 7 $21 $7 $13.571 $6.82 98.99%
2023-06-06 8 $21 $7 $12.875 $6.82 88.78%
2023-07-25 8 $22 $7 $13 $6.82 90.62%
2023-08-14 8 $22 $5 $11.857 $6.82 73.86%
2023-09-20 8 $22 $5 $11.714 $6.82 71.76%
2023-11-15 7 $22 $5 $12.5 $6.82 83.28%

The Trend in the Analyst Price Target


Over the past 21 months, YMAB's average price target has gone down $28.9.

Over the past 45 weeks, YMAB's average upside potential has been 112.83%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 7 20 4 12.142 4.280 183.69%
2023-04-04 7 18 4 10.714 5.750 86.33%
2023-05-09 7 21 5 11.571 9.230 25.36%
2023-10-17 7 22 5 12.833 5.395 137.87%
2023-10-17 7 22 5 12.500 5.395 131.7%

YMAB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.96 4 0 2 0 0 7

The Trend in the Broker Recommendations


YMAB's average broker recommendation rating worsened by 0.5 over the prior 15 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Y-MABS THERAPEUTICS INC's variance in analysts' estimates is lower than -3621.91% of them.
  • Y-MABS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 3390.4% of all US stocks.
  • YMAB has a greater average analyst price target than 1225.15% of stocks in the mid market cap category.
  • In terms of how Y-MABS THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 1772.69% of that group.

Stocks similar to Y-MABS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DCPH, AUPH, and ANAB.

Is YMAB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!